Keyphrases
9p21
11%
Adenocarcinoma
11%
Alternative Splicing
11%
Antitumor Activity
11%
Antitumor Effect
100%
Apoptosis
11%
Apoptosis Induction
11%
ATLAS Project
11%
Autophagy
22%
Cancer Cases
11%
Cancer Genome Atlas
11%
CDKN2A Gene
11%
CDKN2A mutation
11%
Cell Cycle Inhibitors
11%
Cell Cycle Progression
11%
Cell Viability Assay
11%
Control Cell
11%
Cyclin-dependent Kinase
11%
Cyclin-dependent Kinase Inhibitor
100%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
100%
Cytotoxic Effect
11%
Cytotoxicity
11%
Dinaciclib
22%
Driver mutations
11%
Epithelial-to-mesenchymal Transition
11%
Flavopiridol
22%
Gene Inactivation
11%
Histological Subtypes
11%
Lung Adenocarcinoma
11%
Lung Cancer Cells
100%
Molecular Targets
11%
Non-small Cell Lung Cancer (NSCLC)
11%
P14ARF
22%
P16INK4a
22%
Phosphorylation
11%
Squamous Cell Lung Cancer
100%
Targeted Drugs
11%
Treatment Outcome
11%
TUNEL Assay
11%
Western Blot Analysis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
11%
Antitumor Activity
11%
Cell Viability
11%
Cyclin Dependent Kinase
22%
Cyclin Dependent Kinase Inhibitor
100%
Cyclin Dependent Kinase Inhibitor 2A
22%
Cytoprotective Agent
11%
Cytotoxicity
22%
Dinaciclib
22%
Flavopiridol
22%
Lung Adenocarcinoma
11%
Malignant Neoplasm
11%
Molecular Target
11%
Neoplasm
100%
Non Small Cell Lung Cancer
11%
Squamous Cell Lung Carcinoma
100%
Viability Assay
11%
Western Blot
11%
Biochemistry, Genetics and Molecular Biology
Antineoplastic Activity
14%
Autophagy
28%
Cancer Cell
100%
Cell Cycle
14%
Cell Cycle Progression
14%
Cell Viability
14%
Cyclin-Dependent Kinase
100%
Cytotoxicity
28%
Downregulation
14%
Gene Inactivation
14%
Mesenchymal-Epithelial Transition
14%
P14arf
28%
TUNEL Assay
14%
Western Blotting
14%